课题基金 / 基金详情

ACTG A5030-Valganciclovir Pre-Emptive Therapy for CMV

ACTG A5030-Valganciclovir Pre-Emptive Therapy for CMV
ACTG A5030-缬更昔洛韦预防巨细胞病毒治疗
批准号：
6982141
负责人：
CONSTANCE ANN BENSON
金额：
$9.33万
依托单位：
UNIVERSITY OF COLORADO DENVER
依托单位国家：
美国
项目类别：
财政年份：
2004
资助国家：
美国
项目状态：
已结题
起止时间：
2004-04-01 至 2005-03-31
来源：
https://reporter.nih.gov/project-details/6982141
关键词：
HIV infectionsHerpesviridae diseaseantiAIDS agentblood cell countchemopreventionclinical researchcytomegalovirusganciclovirhelper T lymphocytehuman subjecthuman therapy evaluationmicroorganism disease chemotherapypatient oriented researchvirus RNAvirus load

项目成果

CONSTANCE ANN BENSON的其他基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pooled and conventional nucleic acid testing strategies for SARS-CoV-2 to screen direct care research staff and protect HIV patients
A Novel Wireless Ingestible Sensor System for Measurement of Medication Adherence in HIV Treatment and Prevention
A Novel Wireless Ingestible Sensor System for Measurement of medication Adherence in HIV Treatment and Prevention
A Novel Wireless Ingestible Sensor System for Measurement of Medication Adherence in HIV Treatment and Prevention